Glycyl-L-lysine

CAS: 997-62-6

Ref. 3D-AAA99762

Product Information

• Name: Glycyl-L-lysine
• Synonyms: 120: PN: WO2012050923 SEQID: 147 unclaimed protein, 27: PN: WO2021055880 SEQID: 28 claimed protein, 28: PN: US20130123467 SEQID: 31 claimed protein, 57: PN: WO2021047558 SEQID: 57 claimed protein, 96: PN: EP2161028 PAGE: 10 claimed protein, <span class="text-smallcaps">L</span>-Lysine, N²-glycyl-, <span class="text-smallcaps">L</span>-Lysine, glycyl-, Glycyl-<span class="text-smallcaps">L</span>-lysine, L-lysine, glycyl-, Lysine, N²-glycyl-, <span class="text-smallcaps">L</span>-, N²-Glycyllysine, N^α-Glycyl-<span class="text-smallcaps">L</span>-lysine, Nα-Glycyl-L-lysine, Lysine, N2-glycyl-, L-, L-Lysine, N2-glycyl-

Description

Glycyl-L-lysine is a signal peptide that has been shown to be involved in the pathogenic mechanism of diabetes. Glycyl-L-lysine is an amino acid that has been found at high levels in atherosclerotic lesions. Glycyl-L-lysine binds to growth factor β1 and insulin, which are proteins involved in blood glucose regulation. It also activates toll-like receptor 2, which may be due to its ability to stimulate the production of inflammatory cytokines. This protein can be used as a pharmacological agent for balloon injury or other types of tissue damage.

• Brand: Biosynth

Chemical properties

• Molecular weight: 203.24 g/mol
• Formula: C₈H₁₇N₃O₃
• Purity: Min. 95%